RU2224759C2 - Способ получения производных пиразоло [4,3-d]пиримидин-7-она и промежуточные соединения - Google Patents

Способ получения производных пиразоло [4,3-d]пиримидин-7-она и промежуточные соединения Download PDF

Info

Publication number
RU2224759C2
RU2224759C2 RU2001121162/04A RU2001121162A RU2224759C2 RU 2224759 C2 RU2224759 C2 RU 2224759C2 RU 2001121162/04 A RU2001121162/04 A RU 2001121162/04A RU 2001121162 A RU2001121162 A RU 2001121162A RU 2224759 C2 RU2224759 C2 RU 2224759C2
Authority
RU
Russia
Prior art keywords
formula
compound
alcohol
lower alkyl
residue
Prior art date
Application number
RU2001121162/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2001121162A (ru
Inventor
Шарлотт Мойра Норфор АЛЛЕРТОН (GB)
Шарлотт Мойра Норфор Аллертон
Кристофер Гордон БАРБЕР (GB)
Кристофер Гордон Барбер
Кейт Майкл ДЕВРИС (GB)
Кейт Майкл ДЕВРИС
Лоуренс Джеймс ХАРРИС (GB)
Лоуренс Джеймс ХАРРИС
Филип Чарльз ЛЕВЕТТ (GB)
Филип Чарльз Леветт
Джоанна Тереза НЕГРИ (GB)
Джоанна Тереза Негри
Дэвид Джеймс РОУСОН (GB)
Дэвид Джеймс Роусон
Альберт Шо ВУД (GB)
Альберт Шо Вуд
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018660A external-priority patent/GB0018660D0/en
Priority claimed from GB0107526A external-priority patent/GB0107526D0/en
Priority claimed from GB0110251A external-priority patent/GB0110251D0/en
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Publication of RU2001121162A publication Critical patent/RU2001121162A/ru
Application granted granted Critical
Publication of RU2224759C2 publication Critical patent/RU2224759C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2001121162/04A 2000-07-28 2001-07-27 Способ получения производных пиразоло [4,3-d]пиримидин-7-она и промежуточные соединения RU2224759C2 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0107526.6 2000-03-26
GB0018660.1 2000-07-28
GB0018660A GB0018660D0 (en) 2000-07-28 2000-07-28 Pharmaceutically active compounds
GB0107526A GB0107526D0 (en) 2001-03-26 2001-03-26 Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one compounds and intermediates thereof
GB0110251A GB0110251D0 (en) 2001-04-26 2001-04-26 Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof
GB0110251.6 2001-04-26

Publications (2)

Publication Number Publication Date
RU2001121162A RU2001121162A (ru) 2003-07-20
RU2224759C2 true RU2224759C2 (ru) 2004-02-27

Family

ID=27255823

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001121162/04A RU2224759C2 (ru) 2000-07-28 2001-07-27 Способ получения производных пиразоло [4,3-d]пиримидин-7-она и промежуточные соединения

Country Status (17)

Country Link
EP (1) EP1176147A1 (enExample)
JP (1) JP2002105076A (enExample)
KR (1) KR20020010102A (enExample)
CN (1) CN1335317A (enExample)
AR (1) AR035650A1 (enExample)
AU (1) AU754962B2 (enExample)
BR (1) BR0103072A (enExample)
CA (1) CA2354175A1 (enExample)
CZ (1) CZ20012713A3 (enExample)
HK (1) HK1040715A1 (enExample)
HU (1) HUP0103075A3 (enExample)
IL (1) IL144516A0 (enExample)
IN (1) IN191315B (enExample)
MX (1) MXPA01007676A (enExample)
PL (1) PL348935A1 (enExample)
RU (1) RU2224759C2 (enExample)
YU (1) YU51701A (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0106631D0 (en) * 2001-03-16 2001-05-09 Pfizer Ltd Pharmaceutically active compounds
US6831074B2 (en) 2001-03-16 2004-12-14 Pfizer Inc Pharmaceutically active compounds
EP1620437B1 (en) 2003-04-29 2009-06-17 Pfizer Limited 5,7-diaminopyrazolo¬4,3-d pyrimidines useful in the traetment of hypertension
JP2006219373A (ja) * 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
CA2562251C (en) 2004-04-07 2009-04-28 Pfizer Inc. Pyrazolo'4,3-d pyrimidines
ES2343141T3 (es) * 2005-11-16 2010-07-23 F. Hoffmann-La Roche Ag Nuevo procedimiento para la preparacion de thoc.
GB2450268B (en) * 2006-03-17 2011-01-12 Cipla Ltd Synthesis of 4-[1-(4-cyano phenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile and 4-[1-(1,2,4-triazol-1-yl)methyl]benzonitrile intermediate
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CA2693169C (en) * 2007-07-19 2016-01-12 Metabolex, Inc. N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
CN102666553B (zh) 2009-10-01 2015-05-06 赛马拜制药公司 取代的四唑-1-基-苯氧基甲基-噻唑-2-基-哌啶基-嘧啶盐
ES2676209T3 (es) 2010-06-23 2018-07-17 Metabolex Inc. Composiciones de 5-etil-2-{4-[4-(4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
JP2019527693A (ja) 2016-08-03 2019-10-03 サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 炎症性胃腸疾患または胃腸状態を治療するためのオキシメチレンアリール化合物
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2114114C1 (ru) * 1990-06-20 1998-06-27 Пфайзер Инк. Пиразолопиримидиноновые соединения, фармацевтическая композиция и способ лечения
RU2114113C1 (ru) * 1991-07-09 1998-06-27 Пфайзер Инк. Пиразолопиримидиноны, фармацевтическая композиция и способ ингибирования фосфодиэстеразы циклического гуанозин-3',5'-монофосфата
WO2001027112A1 (en) * 1999-10-11 2001-04-19 Pfizer Limited 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2089971A (en) * 1937-08-17 Condensation products of
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2114114C1 (ru) * 1990-06-20 1998-06-27 Пфайзер Инк. Пиразолопиримидиноновые соединения, фармацевтическая композиция и способ лечения
RU2114113C1 (ru) * 1991-07-09 1998-06-27 Пфайзер Инк. Пиразолопиримидиноны, фармацевтическая композиция и способ ингибирования фосфодиэстеразы циклического гуанозин-3',5'-монофосфата
WO2001027112A1 (en) * 1999-10-11 2001-04-19 Pfizer Limited 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
кол. 7-8. DUMAITRE В., DODIC N. Synthesis and cyclic GMP phosphodiesterase inhibitory activity of series of 6-phenylpyrasolo[3,4-d]pyrimidones. J. Med. Chem. V.39, no.8, 1996, p.1635-1644. HAMILTON H.W. et.al. Synthesis and structure-activity relationships of pyrasolo[3,4-d]pyrimidin-7-ones as adenosine reseptor antagonist. J. Med. Chem. V.30, no.1, 1987, p.91-96. *
кол.16-17. *

Also Published As

Publication number Publication date
CA2354175A1 (en) 2002-01-28
MXPA01007676A (es) 2002-10-23
YU51701A (sh) 2003-12-31
HK1040715A1 (zh) 2002-06-21
HUP0103075A2 (hu) 2002-07-29
JP2002105076A (ja) 2002-04-10
KR20020010102A (ko) 2002-02-02
CZ20012713A3 (cs) 2002-04-17
HUP0103075A3 (en) 2003-04-28
AU754962B2 (en) 2002-11-28
CN1335317A (zh) 2002-02-13
EP1176147A1 (en) 2002-01-30
AU5767201A (en) 2002-01-31
IN191315B (enExample) 2003-11-22
IL144516A0 (en) 2002-05-23
PL348935A1 (en) 2002-02-11
HU0103075D0 (en) 2001-10-28
BR0103072A (pt) 2002-04-09
AR035650A1 (es) 2004-06-23

Similar Documents

Publication Publication Date Title
RU2224759C2 (ru) Способ получения производных пиразоло [4,3-d]пиримидин-7-она и промежуточные соединения
DK2488512T3 (en) CGRP receptor antagonists
ES2380098T3 (es) Procedimiento de preparación de una piperidina disustituida y productos intermedios
BR112019020459A2 (pt) compostos que inibem a proteína mcl-1
UA122219C2 (uk) Сполуки піразину для лікування інфекційних захворювань
CA2918217C (fr) Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP3325477A1 (en) Novel tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
KR20190115067A (ko) 피롤로[1,2-b]피리딘 유도체
JP2007515442A5 (enExample)
CA2548323A1 (en) Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions
WO2003053975A1 (en) Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
EA027569B1 (ru) Производные пиридина
ES2226297T3 (es) Procedimdiento e intermediarios de hydantoina para la sintesis de secretagogos de la hormona del crecimiento.
KR20180008637A (ko) ｛1-(에틸술포닐)-3-[4-(7H-피롤로[2,3-d]피리미딘-4-일)-1H-피라졸-1-일]아제티딘-3-일｝아세토니트릴의 제조를 위한 방법 및 중간체
WO2015172732A1 (zh) 作为二肽基肽酶-iv抑制剂的氨基四氢吡喃衍生物
JP2015528013A (ja) 置換ウレア化合物の合成方法
NL1028193C2 (nl) Farmaceutisch werkzame verbindingen.
RU2004135088A (ru) Способ получения производных 6-алкилиденпенема
RU2006129164A (ru) Цианопиримидиноны
RU2001106627A (ru) Способ получения n,n,6-триметил-2-(4-метилфенил)-имидазо-[1,2-а]-пиридин-3-ацетамида и его солей
AU764122B2 (en) Process for preparing growth hormone secretagogues
JP2008538554A (ja) タダラフィルの中間体の調製
AU6543600A (en) Process for the preparation of pyrazolo(4,3-d)pyrimidin-7- ones-3-pyridylsulphonyl compounds and intermediates thereof
RU2008116573A (ru) Химический способ
CN119630660A (zh) 一种抑制irak4活性的化合物及其应用

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20040728